Abstract
Scientific evidence of the efficacy of magnetoencephalography (MEG) is currently lacking except in diagnosing epilepsy. In the present study, we performed a review of clinical MEG studies on neurodegenerative disorders using a website bibliographic survey. We searched MEDLINE for MEG papers on neurodegenerative disorders published before December 2014 using the following keywords: a representative diagnosis such as amyotrophic lateral sclerosis (ALS) and magnetoencephalography or MEG. We further narrowed the search to 30 papers based on the levels of evidence and abstract contents; 3 papers on ALS, 18 papers on Parkinson disease, and 9 papers on multiple sclerosis were included in the final review. Levels of evidence were classified as follows: grade I, no paper; grade II, 19 papers; grade III, 2 papers; and grade IV, 9 papers. The majority of studies were conducted with a small number of patients. However, MEG has the advantage of being able to detect spontaneous activity in small brain regions and to measure functional network activity between multiple brain areas or coherent activity between deep brain nuclei and distinct cortical areas. Accordingly, MEG allows the assessment of functional changes in certain diseases and provides novel insights into disease-specific pathophysiology, such as in Parkinson disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
McCormick KA, Fleming B. Clinical practice guidelines. The Agency for Health Care Policy and Research fosters the development of evidence-based guidelines. Health Prog. 1992;73:30–4.
Brown RH, Cannon SC, Rowland LP. Chapter 14: Diseases of the nerve and motor unit. In: Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ, editors. Principles of neural sciences. 5th ed. New York: McGraw-Hill Professional; 2012. p. 307–30.
Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology. Manag Ther Trials Aging Dis. 2013;4(5):295–310.
Pekkonen E, Osipova D, Laaksovirta H. Magnetoencephalographic evidence of abnormal auditory processing in amyotrophic lateral sclerosis with bulbar signs. Clin Neurophysiol. 2004;115(2):309–15.
Boyajian RA, Amo C, Otis SM, Romine JS, Smith RA. Magnetic source imaging of cortical dysfunction in amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2008;87(6):427–37.
Teismann IK, Warnecke T, Suntrup S, Steinsträter O, Kronenberg L, Ringelstein EB, Dengler R, Petri S, Pantev C, Dziewas R. Cortical processing of swallowing in ALS patients with progressive dysphagia—a magnetoencephalographic study. PLoS One. 2011;6(5):e19987. doi:10.1371/journal.pone.0019987.
Wichmann T, DeLong MR. Chapter 43: The basal ganglia. In: Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ, editors. Principles of neural sciences. 5th ed. New York: McGraw-Hill Professional; 2012. p. 982–98.
Gale JT, Amirnovin R, Williams ZM, Flaherty AW, Eskandar EN. From symphony to cacophony: pathophysiology of the human basal ganglia in Parkinson disease. Neurosci Biobehav Rev. 2008;32(3):378–87.
Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol. 1996;50(4):381–425.
Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318(1):121–34.
Hawkes CH, Del Tredici K, Braak H. Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33(6):599–614.
Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ. Slowing of oscillatory brain activity is a stable characteristic of Parkinson’s disease without dementia. Brain. 2007;130(Pt 7):1847–60.
Boesveldt S, Stam CJ, Knol DL, Verbunt JP, Berendse HW. Advanced time-series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson’s disease patients. Hum Brain Mapp. 2009;30(9):3020–30.
Gómez C, Olde Dubbelink KT, Stam CJ, Abásolo D, Berendse HW, Hornero R. Complexity analysis of resting-state MEG activity in early-stage Parkinson’s disease patients. Ann Biomed Eng. 2011;39(12):2935–44.
Olde Dubbelink KT, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Berendse HW. Cognitive decline in Parkinson’s disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging. 2013;34(2):408–18.
Olde Dubbelink KT, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Hillebrand A, Berendse HW. Resting-state functional connectivity as a marker of disease progression in Parkinson’s disease: a longitudinal MEG study. Neuroimage Clin. 2013;2:612–9.
Olde Dubbelink KT, Hillebrand A, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Berendse HW. Disrupted brain network topology in Parkinson’s disease: a longitudinal magnetoencephalography study. Brain. 2014;137(Pt 1):197–207.
Olde Dubbelink KT, Hillebrand A, Twisk JW, Deijen JB, Stoffers D, Schmand BA, Stam CJ, Berendse HW. Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers. Neurology. 2014;82(3):263–70.
Vardy AN, van Wegen EE, Kwakkel G, Berendse HW, Beek PJ, Daffertshofer A. Slowing of M1 activity in Parkinson’s disease during rest and movement – an MEG study. Clin Neurophysiol. 2011;122(4):789–95.
Pollok B, Makhloufi H, Butz M, Gross J, Timmermann L, Wojtecki L, Schnitzler A. Levodopa affects functional brain networks in Parkinsonian resting tremor. Mov Disord. 2009;24(1):91–8.
Pollok B, Krause V, Martsch W, Wach C, Schnitzler A, Südmeyer M. Motor-cortical oscillations in early stages of Parkinson’s disease. J Physiol. 2012;590(Pt 13):3203–12.
Litvak V, Jha A, Eusebio A, Oostenveld R, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P. Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson’s disease. Brain. 2011;134(Pt2):359–74.
Litvak V, Eusebio A, Jha A, Oostenveld R, Barnes G, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P. Movement-related changes in local and long-range synchronization in Parkinson’s disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci. 2012;32(31):10541–53.
Hirschmann J, Özkurt TE, Butz M, Homburger M, Elben S, Hartmann CJ, Vesper J, Wojtecki L, Schnitzler A. Distinct oscillatory STN-cortical loops revealed by simultaneous MEG and local field potential recordings in patients with Parkinson’s disease. Neuroimage. 2011;55(3):1159–68.
Hirschmann J, Özkurt TE, Butz M, Homburger M, Elben S, Hartmann CJ, Vesper J, Wojtecki L, Schnitzler A. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson’s disease. Neuroimage. 2013;68:203–13.
Hirschmann J, Hartmann CJ, Butz M, Hoogenboom N, Ozkurt TE, Elben S, Vesper J, Wojtecki L, Schnitzler A. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson’s disease. Brain. 2013;136(Pt 12):3659–70.
Airaksinen K, Mäkelä JP, Taulu S, Ahonen A, Nurminen J, Schnitzler A, Pekkonen E. Effects of DBS on auditory and somatosensory processing in Parkinson’s disease. Hum Brain Mapp. 2011;32(7):1091–9.
Airaksinen K, Butorina A, Pekkonen E, Nurminen J, Taulu S, Ahonen A, Schnitzler A, Mäkelä JP. Somatomotor mu rhythm amplitude correlates with rigidity during deep brain stimulation in Parkinsonian patients. Clin Neurophysiol. 2012;123(10):2010–7.
Airaksinen K, Mäkelä JP, Nurminen J, Luoma J, Taulu S, Ahonen A, Pekkonen E. Cortico-muscular coherence in advanced Parkinson’s disease with deep brain stimulation. Clin Neurophysiol. 2014 (in press). doi:http://dx.doi.org/10.1016/j.clinph.2014.07.025.
Leary S, Giovannoni G, Howard R, Miller D, Thompson A. Chapter 10: Multiple sclerosis and demyelinating diseases. In: Clarke C, Howard R, Rossor M, Shorvon SD, editors. Neurology: a queen square textbook. Singapore: Willy-Blackwell; 2009. p. 411–47.
Tecchio F, Zito G, Zappasodi F, Dell’ Acqua ML, Landi D, Nardo D, Lupoi D, Rossini PM, Filippi MM. Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach. Brain. 2008;131(Pt 7):1783–92.
Dell’Acqua ML, Landi D, Zito G, Zappasodi F, Lupoi D, Rossini PM, Filippi MM, Tecchio F. Thalamocortical sensorimotor circuit in multiple sclerosis: an integrated structural and electrophysiological assessment. Hum Brain Mapp. 2010;31(10):1588–600.
Hagiwara K, Okamoto T, Shigeto H, Ogata K, Somehara Y, Matsushita T, Kira J, Tobimatsu S. Oscillatory gamma synchronization binds the primary and secondary somatosensory areas in humans. Neuroimage. 2010;51(1):412–20.
Schoonheim MM, Geurts JJ, Landi D, Douw L, van der Meer ML, Vrenken H, Polman CH, Barkhof F, Stam CJ. Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data. Hum Brain Mapp. 2013;34(1):52–61.
Hardmeier M, Schoonheim MM, Geurts JJ, Hillebrand A, Polman CH, Barkhof F, Stam CJ. Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magnetoencephalography. PLoS One. 2012;7(7):e42087. doi:10.1371/journal. pone.0042087.
Tewarie P, Schoonheim MM, Stam CJ, van der Meer ML, van Dijk BW, Barkhof F, Polman CH, Hillebrand A. Cognitive and clinical dysfunction, altered MEG resting-state networks and thalamic atrophy in multiple sclerosis. PLoS One. 2013;8(7):e69318. doi:10.1371/journal.pone.0069318.
Tewarie P, Hillebrand A, Schoonheim MM, van Dijk BW, Geurts JJ, Barkhof F, Polman CH, Stam CJ. Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: an MEG source-space study. Neuroimage. 2014;88:308–18.
Tewarie P, Steenwijk MD, Tijms BM, Daams M, Balk LJ, Stam CJ, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F, Pouwels PJ, Vrenken H, Hillebrand A. Disruption of structural and functional networks in long-standing multiple sclerosis. Hum Brain Mapp. 2014;35(12):5946–61. doi:10.1002/hbm.22596.
Tewarie P, Schoonheim MM, Schouten DI, Polman CH, Balk LJ, Uitdehaag BM, Geurts JJ, Hillebrand A, Barkhof F, Stam CJ. Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Hum Brain Mapp. 2015;36(2):603–18.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Ozaki, I., Hashimoto, I. (2016). Neurodegenerative Disorders. In: Tobimatsu, S., Kakigi, R. (eds) Clinical Applications of Magnetoencephalography. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55729-6_12
Download citation
DOI: https://doi.org/10.1007/978-4-431-55729-6_12
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55728-9
Online ISBN: 978-4-431-55729-6
eBook Packages: MedicineMedicine (R0)